Pulsenmore Ltd.

PROXY MATERIALS

Copies of the proxy card, the notice of the Meeting and this Proxy Statement are available athttps://pulsenmore.com/investor_relations/. Information about the Meeting can also be found on the Investor Relations section of our website. The contents of our and any other website are not incorporated by reference into this Proxy Statement.

Item no. 1

TO RE-ELECT EACH OF MS. Rachel Guz-Lavi and MR. Hagai Itkin to serve as Class I directors of the Company

The Articles provide that the number of directors may be no less than 5 and no more than 10 (including external directors to the extent required to be appointed to the Board of Directors pursuant to the Companies Law, and independent directors).

The directors (excluding external directors, to the extent external directors are required to be elected and to serve on the Board of Directors pursuant to the requirements of the Companies Law), shall be classified, with respect to the term for which they each severally hold office, into three classes, as nearly equal in number as practicable, hereby designated as Class I, Class II and Class III (each, a “Class”). The Board of Directors may assign members of the Board of Directors already in office to such classes at the time such classification becomes effective.

In accordance with the Articles, the term of office of the initial Class I directors shall commence on the Annual Meeting (as defined in the Articles) held in 2025 and shall expire at the 2026 Annual Meeting (i.e. at the Meeting) and when their successors are elected and qualified. At each Annual Meeting, commencing with the 2026 Annual Meeting, each nominee or alternate nominee (each as defined in the Articles) elected at such Annual Meeting to serve as a director in a Class whose term shall have expired at such Annual Meeting shall be elected to hold office until the third Annual Meeting next succeeding his or her election and until his or her respective successor shall have been elected and qualified. Notwithstanding anything to the contrary, each director shall serve until his or her successor is elected and qualified or until such earlier time as such director’s office is vacated. Our initial Class I directors are Ms. Rachel Guz-Lavi and Mr. Hagai Itkin.

Following the recommendation of our Board of Directors, it is proposed that each of Ms. Rachel Guz-Lavi and Mr. Hagai Itkin be re-elected as a Class I director to hold office until the third Annual Meeting next succeeding her or his re-election and until her or his successor shall have been elected and qualified or until such earlier time as her or his office is vacated.

In accordance with Israeli law, a nominee for service as a director must submit a declaration to the Company, prior to his or her nomination, specifying that he or she has the requisite qualifications to serve as a director, and the ability to devote the appropriate time to performing his or her duties as such. Each of Ms. Guz-Lavi and Mr. Itkin has declared in writing that they possess the requisite skills and expertise, as well as sufficient time, to perform their respective duties as a director of the Company.

In addition, our Board of Directors has classified each of Ms. Guz-Lavi and Mr. Itkin as “independent director,” as defined under the Nasdaq Listing Rules. In accordance with the Israeli Companies Regulations (Alleviation for Public Companies whose shares are Traded on the Stock Exchange Outside of Israel), 2000 (the “Alleviation Regulations”) (as it applies to companies whose shares are traded on certain foreign stock exchanges, including Nasdaq), pursuant to which, if a nominee for service as a director qualifies as independent in accordance with the law of the relevant foreign jurisdiction and does not have any affiliation with a “controlling shareholder” (as defined in the Companies Law), the Audit Committee may classify him or her as independent in accordance with the Companies Law. Accordingly, our Audit Committee has classified each of Ms. Guz-Lavi and Mr. Itkin as independent in accordance with the Companies Law, as supplemented by the Alleviation Regulations, as well.

Furthermore, each of Ms. Guz-Lavi and Mr. Itkin currently serves on the Audit Committee and is classified as “independent” as such term is defined in Rule 10A-3(b)(1) under the U.S. Securities Exchange Act of 1934, as amended, which provides additional qualification criteria to the general test for independence of board and committee members under the Nasdaq Listing Rules. Additionally, each of Ms. Guz-Lavi and Mr. Itkin is financially literate under the applicable rules and regulations of the SEC and Nasdaq Listing Rules and has the requisite financial experience required under the Nasdaq Listing Rules. In addition, pursuant to the Companies Law, the board of directors of a publicly traded company is required to make a determination as to the minimum number of directors who must have financial and accounting expertise according to criteria set forth under the Companies Law and regulations promulgated thereunder and based, among other things, on the type of company, its size, the volume and complexity of the company’s activities and the number of directors. The Board has determined that the minimum number of directors with financial and accounting expertise is one. Currently, another member of our Audit Committee, Mrs. Linda Messalem, qualifies as such.

Below are brief biographies of each of Ms. Guz-Lavi and Mr. Itkin, based upon information furnished to us by them:

Racheli Guz-Lavi. Ms. Racheli Guz-Lavi has served as member of our Board of Directors since 2020. Ms. Guz-Lavi is a managing partner at Amit Pollak Matalon & Co. (APM & Co.) law firm and senior partner of the tax department having joined the firm in 2007. Prior to joining APM & Co., Ms. Guz-Lavi was a partner at Dan-Ben Dror & Co., a taxation focused law firm, and worked as a CPA at KPMG Israel. Ms. Guz-Lavi is a certified CPA since 1995 and a member of the Israeli Bar since 1997. Ms. Guz-Lavi has previously served on the boards of Arim Urban Development Company Ltd, Peninsula Ltd and Medigus Ltd (now Xylo Technologies Ltd) among others. Ms. Guz-Lavi holds a B.A. in Economics and Accounting from Tel-Aviv University as well as an LL.M. from Bar-Ilan University and an LL.B. from Tel-Aviv University.

Hagai Itkin. Mr. Itkin has held various leadership roles since 1987. He currently serves as Chairman of Ramot, the Technology Transfer Company of Tel Aviv University, and of TAU Venture, Tel Aviv University’s venture capital fund. In addition, Mr. Itkin serves as Executive Director of Industry Relationships at Tel Aviv University since June 2024, and as a partner at I NEXT Capital, an early-stage digital health venture capital fund, since May 2023. Mr. Itkin currently serves as a board member of several companies, including Discount Capital Ltd. (since August 2024), Actual-Signal, a healthcare start-up (since November 2024), MarbleX, a start-up company in space sensing (since March 2024), and NGV.EARTH, a clean energy company (since January 2023). He also serves on the advisory boards of CyberproAI (since August 2022) and Aurlius Capital (since September 2024). Additionally, he has served as a consultant to Sicpa SA (since August 2021) and the start-up Knock-Eat, a start-up focused on equine solutions (since September 2024). Between 2004 and 2020, Mr. Itkin held senior positions in the government sector in Israel and abroad. Mr. Itkin holds a B.A. in Economics & Business Administration from the Hebrew University of Jerusalem (1996–1999), a Master of Business Administration (MBA) from Ben Gurion University (2007–2010), and completed a Director and Senior Executive Training Program at Tel Aviv University in 2021.

Subject to their re-appointment to the Board of Directors as Class I directors, each of Ms. Guz-Lavi and Mr. Itkin shall be entitled to an annual fee and a per meeting fee of the fixed amounts set under the Companies Law in accordance with our then-effective grade, so that as of January 1, 2026 and according to our equity as of December 31, 2025, each of them shall be entitled to an annual fee of NIS 74 thousand (approximately $25 thousand, based on the NIS/US$ representative exchange rate as published by the Bank of Israel on June 29, 2026; the “Exchange Rate”) and a per meeting fee of NIS 4 thousand (approximately $1 thousand, based on the Exchange Rate). In addition, each of Ms. Guz-Lavi and Mr. Itkin shall be entitled to indemnification and exculpation pursuant to the indemnification agreements of the Company as in effect from time to time and to insurance pursuant to the Company’s applicable insurance policies. As the abovementioned amounts are within the range between the fixed amounts set forth in the Israeli regulations promulgated under the Companies Law concerning the remuneration of external directors and the maximum amounts set forth in the Alleviation Regulations, they are exempt from shareholder approval, in accordance with the Israeli Companies Regulations (Relief from Related Party Transactions), 2000 and the shareholders will not vote on the approval thereof. These cash amounts are subject to an annual adjustment for changes in the Israeli consumer price index and to an annual adjustment in accordance with the classification of the Company according to the size of its capital. VAT shall be added to the above compensation in accordance with applicable law. Director nominees may assign their right to remunerations to the shareholder that appointed them.